Ubs Group Ag Azenta, Inc. Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

A detailed history of Ubs Group Ag transactions in Azenta, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 37,249 shares of AZTA stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,249

Previous 39,410 5.48%

Holding current value

$1.57 Million

Previous $2.38 Million 17.47%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$50.27 - $59.04 $108,633 - $127,585	-2,161 Reduced 5.48%	37,249 $1.96 Million
Q1 2024 May 13, 2024	BUY	$57.82 - $67.51 $1.14 Million - $1.34 Million	19,779 Added 100.75%	39,410 $2.38 Million
Q4 2023 Feb 09, 2024	BUY	$44.02 - $66.3 $19,764 - $29,768	449 Added 2.34%	19,631 $1.28 Million
Q3 2023 Nov 09, 2023	SELL	$44.08 - $57.76 $175,482 - $229,942	-3,981 Reduced 17.19%	19,182 $962,000
Q2 2023 Aug 11, 2023	SELL	$36.45 - $46.68 $503,921 - $645,351	-13,825 Reduced 37.38%	23,163 $1.08 Million
Q1 2023 May 12, 2023	SELL	$39.51 - $61.95 $719,753 - $1.13 Million	-18,217 Reduced 33.0%	36,988 $1.65 Million
Q4 2022 Feb 08, 2023	BUY	$38.6 - $62.07 $533,490 - $857,869	13,821 Added 33.4%	55,205 $3.21 Million
Q3 2022 Nov 10, 2022	SELL	$42.86 - $77.02 $817,811 - $1.47 Million	-19,081 Reduced 31.56%	41,384 $1.77 Million
Q2 2022 Aug 10, 2022	SELL	$64.69 - $85.07 $47,482 - $62,441	-734 Reduced 1.2%	60,465 $4.36 Million
Q1 2022 May 16, 2022	SELL	$76.3 - $103.81 $3.46 Million - $4.71 Million	-45,367 Reduced 42.57%	61,199 $5.07 Million
Q4 2021 Feb 14, 2022	BUY	$92.98 - $124.15 $1.56 Million - $2.08 Million	16,730 Added 18.62%	106,566 $11 Million
Q3 2021 Nov 15, 2021	SELL	$77.49 - $109.17 $12.9 Million - $18.1 Million	-165,891 Reduced 64.87%	89,836 $9.19 Million
Q2 2021 Aug 13, 2021	BUY	$86.59 - $107.47 $5.12 Million - $6.35 Million	59,131 Added 30.08%	255,727 $24.4 Million
Q1 2021 May 12, 2021	BUY	$66.32 - $90.93 $3.3 Million - $4.53 Million	49,773 Added 33.9%	196,596 $16.1 Million
Q4 2020 Feb 11, 2021	BUY	$46.7 - $75.22 $1.86 Million - $2.99 Million	39,725 Added 37.09%	146,823 $9.96 Million
Q3 2020 Nov 12, 2020	BUY	$42.77 - $56.69 $2.05 Million - $2.72 Million	48,040 Added 81.34%	107,098 $4.95 Million
Q2 2020 Jul 31, 2020	SELL	$26.54 - $44.24 $569,017 - $948,505	-21,440 Reduced 26.63%	59,058 $2.61 Million
Q1 2020 May 01, 2020	SELL	$22.69 - $44.14 $1.11 Million - $2.16 Million	-48,914 Reduced 37.8%	80,498 $2.46 Million
Q4 2019 Feb 14, 2020	BUY	$35.49 - $48.05 $1.64 Million - $2.23 Million	46,314 Added 55.73%	129,412 $5.43 Million
Q3 2019 Nov 14, 2019	BUY	$30.18 - $41.75 $2.09 Million - $2.89 Million	69,111 Added 494.11%	83,098 $3.08 Million
Q2 2019 Aug 14, 2019	SELL	$29.53 - $41.1 $1.78 Million - $2.48 Million	-60,273 Reduced 81.16%	13,987 $542,000
Q1 2019 May 14, 2019	BUY	$24.38 - $33.75 $1.06 Million - $1.47 Million	43,484 Added 141.29%	74,260 $2.18 Million
Q4 2018 Feb 14, 2019	SELL	$23.22 - $35.29 $552,775 - $840,113	-23,806 Reduced 43.62%	30,776 $805,000
Q3 2018 Nov 14, 2018	BUY	$28.71 - $39.6 $931,984 - $1.29 Million	32,462 Added 146.75%	54,582 $1.91 Million
Q2 2018 Aug 14, 2018	BUY	$24.88 - $36.36 $399,423 - $583,723	16,054 Added 264.66%	22,120 $721,000
Q1 2018 May 15, 2018	SELL	$23.3 - $30.15 $111,257 - $143,966	-4,775 Reduced 44.05%	6,066 $164,000
Q4 2017 Feb 14, 2018	SELL	$22.54 - $34.39 $687,965 - $1.05 Million	-30,522 Reduced 73.79%	10,841 $259,000
Q3 2017 Nov 14, 2017	BUY	$22.6 - $30.36 $530,941 - $713,247	23,493 Added 131.47%	41,363 $1.26 Million
Q2 2017 Aug 14, 2017	BUY	N/A	4,503 Added 33.69%	17,870 $388,000
Q1 2017 Nov 14, 2017	BUY	N/A	13,367	13,367 $299,000

Others Institutions Holding AZTA

# of Institutions

338

Shares Held

53.7M

Call Options Held

260K

Put Options Held

238K

View Full List

About Azenta, Inc.

Ticker AZTA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 75,020,400
Market Cap $3.16B
Description
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sampl...

More about AZTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account